A Japanese multi-institutional phase II study of moderate hypofractionated intensity-modulated radiotherapy with image-guided technique for prostate cancer-Reference-Cited by-同舟云学术

A Japanese multi-institutional phase II study of moderate hypofractionated intensity-modulated radiotherapy with image-guided technique for prostate cancer

Published:2024-04-17 Issue:6 Volume:29 Page:847-852
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Nakamura Katsumasa^ORCID,Nihei Keiji,Saito Yoshihiro,Shikama Naoto,Noda Shin-ei,Hara Ryusuke,Imagumbai Toshiyuki,Mizowaki Takashi,Akiba Takeshi,Kunieda Etsuo,Someya Masanori,Ohga Saiji,Kawamori Jiro,Kozuka Takuyo,Ota Yosuke,Inaba Koji,Kodaira Takeshi,Itoh Yoshiyuki,Funakoshi Kouta,Kagami Yoshikazu

Funder

Health Labor Sciences Research Grant

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10147-024-02517-z.pdf

Reference18 articles.

1. Nakamura K, Akimoto T, Mizowaki T et al (2012) Patterns of practice in intensity-modulated radiation therapy and image-guided radiation therapy for prostate cancer in Japan. Jpn J Clin Oncol 42:53–57

2. Numasaki H, Nakada Y, Okuda Y et al (2022) Japanese structure survey of radiation oncology in 2015. J Radiat Res 63:230–246

3. Nakamura K, Ishikawa H, Akimoto T et al (2020) National survey of radiation oncologists’ practice patterns regarding hormone-naïve prostate cancer with bone metastases. Jpn J Clin Oncol 50:1188–1194

4. Dearnaley D, Syndikus I, Mossop H et al (2016) Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Lancet Oncol 17:1047–1060

5. Incrocci L, Wortel RC, Alemayehu WG et al (2016) Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial. Lancet Oncol 17:1061–1069

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of androgen‐deprivation therapy for intermediate‐ and high‐risk prostate cancer treated with high‐dose radiotherapy: A literature review;International Journal of Urology;2024-07-17

2. Spatial Pattern of Intraprostatic Recurrence after Definitive External-Beam Radiation Therapy for Prostate Cancer: Implications for Focal Boost to Intraprostatic Dominant Lesion;Advances in Radiation Oncology;2024-06